Journal of Pain Research (Oct 2020)
Levorphanol in the Perioperative Setting: Decreasing Opioid Requirements While Improving Pain Management
Abstract
Christopher R Page, Carlos Andres Perez, Ana Mavarez-Martinez, Sara Khan, Sergio D Bergese Department of Anesthesiology, Stony Brook University Hospital, Stony Brook, NY, USACorrespondence: Christopher R Page Email [email protected]: Levorphanol is a Food and Drug Administration (FDA)-approved long-acting opioid. Most information on perioperative use of levorphanol comes from the early- and mid-1950s when this drug emerged in the field of experimental pharmacology and anesthesia. It was mainly studied during this period with some additional data being generated in the 1960s and 70s. Since this time, perioperative use has declined and research is limited. This review of literature aims to provide pharmacologic and historic description of levorphanol as a tool for perioperative pain management and as an aid to potentially decrease total postoperative opioid use during the current opioid crisis.Keywords: levorphanol, methadone, long-acting opioid, perioperative analgesia
